Data as of Q4 2025 (Dec 31, 2025)

BIOHARVEST SCIENCES INC.

(BHST)

Financial Statements · SEC EDGAR XBRL

Revenue
$34.5M
+37.0%
Net Income
-$11.1M
+13.8%
Gross Margin
59.3%
Op. Income
-$5.6M
+20.2%
FCF
-$9.6M
-0.7%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
FY 2025
FY 2024
FY 2023
$34.5M
$25.2M
$12.7M
$34.5M
$25.2M
$12.7M
$14.0M
$11.2M
$7.0M
$20.5M
$13.9M
$5.6M
$26.1M
$20.9M
$15.6M
-$5.6M
-$7.0M
-$10.0M
-$11.1M
-$12.9M
-$12.6M
-$76K
-$8K
$0
-$11.1M
-$12.9M
-$12.6M
$-0.60
$-0.80
$-0.93